Literature DB >> 31634230

Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry Study.

Himal Kandel1, Konrad Pesudovs2, Alex Ferdi1, Richard Mills3, Jern Yee Chen3, Adam Watson4, Alexander Poon5, Laura E Downie6, Stephanie L Watson1.   

Abstract

PURPOSE: The aim of this study was to evaluate the psychometric properties of the Keratoconus Outcomes Research Questionnaire (KORQ) in patients enrolled in the Save Sight Keratoconus Registry.
METHODS: A cross-sectional study was conducted utilizing prospectively collected web-based registry data. The psychometric properties of the KORQ were assessed using both classical test theory and Rasch analysis. Andrich group rating scale variant of the Rasch analysis was conducted using Winsteps software, Version 3.92.1.
RESULTS: The KORQ was completed by 189 patients with keratoconus (men, 67.7%; white, 69.8%; median age 29 years; better eye median values: visual acuity, 75 LogMAR letters; Kmax, 51.3 D; K2, 46.5 D; thinnest pachymetry, 485 μm). Cronbach's α for the "Activity Limitation" and "Symptoms" scales were 0.95 and 0.91, respectively, with both scales free from floor or ceiling effects. On Rasch analysis, the category thresholds were ordered and well-spaced for both scales. The Activity Limitation scale had excellent psychometric properties including person separation index (3.6), unidimensionality (variance explained, 65.4%), fit statistics (<1.3 MnSq), and measurement range (3.6 logits). Similarly, the Symptoms scale had satisfactory psychometric properties including person separation index (2.5), unidimensionality (variance explained, 54.3%), fit statistics (<1.30 MnSq except for 1 item), and measurement range (2.0 logits). Both scales were well targeted to the population and free of differential item functioning.
CONCLUSIONS: The KORQ is a psychometrically robust patient-reported outcome measure for evaluating quality of life parameters in keratoconus. It enables routine collection and monitoring of meaningful patient-reported outcome data in clinical settings, including registries.

Entities:  

Mesh:

Year:  2020        PMID: 31634230     DOI: 10.1097/ICO.0000000000002169

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Both Subjective Emotional Distress and Visual Handicap Correlate with Belin ABCD Classification in the Worse Eye as Measured with the "Keratoconus End-Points Assessment Questionnaire" (KEPAQ).

Authors:  Kepa Balparda; Tatiana Herrera-Chalarca; Laura Andrea Silva-Quintero; Sneider Alexander Torres-Soto; Laura Segura-Muñoz; Claudia Marcela Vanegas-Ramirez
Journal:  Clin Ophthalmol       Date:  2020-06-30

2.  Development and Validation of the "Keratoconus End-Points Assessment Questionnaire" (KEPAQ), a Disease-Specific Instrument for Evaluating Subjective Emotional Distress and Visual Function Through Rasch Analysis.

Authors:  Kepa Balparda; Tatiana Herrera-Chalarca; Laura Andrea Silva-Quintero; Sneider Alexander Torres-Soto; Claudia Marcela Vanegas-Ramírez
Journal:  Clin Ophthalmol       Date:  2020-05-12

3.  Standardizing the measurement and classification of quality of life using the Keratoconus End-Points Assessment Questionnaire (KEPAQ): the ABCDEF keratoconus classification.

Authors:  Kepa Balparda; Tatiana Herrera-Chalarca; Melissa Cano-Bustamante
Journal:  Eye Vis (Lond)       Date:  2022-05-08

4.  Quality of life impact of eye diseases: a Save Sight Registries study.

Authors:  Himal Kandel; Vuong Nguyen; Stefano Piermarocchi; Lala Ceklic; Kelvin Teo; Francisco Arnalich-Montiel; Stefania Miotto; Vincent Daien; Mark C Gillies; Stephanie L Watson
Journal:  Clin Exp Ophthalmol       Date:  2022-02-07       Impact factor: 4.383

5.  Quality of life in keratoconus: evaluation with Keratoconus Outcomes Research Questionnaire (KORQ).

Authors:  Roberto Damian Pacheco Pinto; Ricardo Yuji Abe; Flávia Cid Gomes; Paulo Rodolfo Tagliari Barbisan; Alexandre Fattah Martini; Daniel de Almeida Borges; Arthur Gustavo Fernandes; Carlos Eduardo Leite Arieta; Monica Alves
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

6.  Rasch analysis for development and reduction of Symptom Questionnaire for Visual Dysfunctions (SQVD).

Authors:  Mario Cantó-Cerdán; Pilar Cacho-Martínez; Francisco Lara-Lacárcel; Ángel García-Muñoz
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

7.  Validation of the Symptom Questionnaire for Visual Dysfunctions (SQVD): A Questionnaire to Evaluate Symptoms of any Type of Visual Dysfunctions.

Authors:  Pilar Cacho-Martínez; Mario Cantó-Cerdán; Francisco Lara-Lacárcel; Ángel García-Muñoz
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.